A detailed history of Copeland Capital Management, LLC transactions in Iradimed Corp stock. As of the latest transaction made, Copeland Capital Management, LLC holds 422,425 shares of IRMD stock, worth $23.7 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares
422,425
Previous 420,992 0.34%
Holding current value
$23.7 Million
Previous $18.5 Million 14.84%
% of portfolio
0.38%
Previous 0.35%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$43.23 - $50.29 $61,948 - $72,065
1,433 Added 0.34%
422,425 $21.2 Million
Q2 2024

Jul 26, 2024

BUY
$40.36 - $44.7 $114,743 - $127,082
2,843 Added 0.68%
420,992 $18.5 Million
Q1 2024

Apr 19, 2024

BUY
$41.17 - $47.29 $17.2 Million - $19.7 Million
417,302 Added 49268.24%
418,149 $18.4 Million
Q4 2023

Jan 19, 2024

BUY
$37.31 - $47.47 $6,790 - $8,639
182 Added 27.37%
847 $40,000
Q3 2023

Oct 23, 2023

BUY
$43.28 - $50.3 $28,781 - $33,449
665 New
665 $29,000

Others Institutions Holding IRMD

About IRADIMED CORP


  • Ticker IRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 12,565,100
  • Market Cap $706M
  • Description
  • IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible pati...
More about IRMD
Track This Portfolio

Track Copeland Capital Management, LLC Portfolio

Follow Copeland Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Copeland Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Copeland Capital Management, LLC with notifications on news.